AQS — Aequus Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Aequus Pharmaceuticals, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	1.72	2.44	0.295	0.215	0.05
Net Total Accounts Receivable
Net Total Receivables	0.78	0.941	0.31	0.032	0.058
Total Inventory
Prepaid Expenses
Total Current Assets	2.77	3.59	0.903	0.436	0.282
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.366	0.242	0.789	0.651	0.518
Net Intangible Assets
Long Term Notes Receivable
Total Assets	3.13	4.35	1.69	1.09	0.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	0.384	2.46	2.38	4.8	6.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	2.56	2.56	3.07	5.38	7.26
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	0.574	1.79	-1.38	-4.29	-6.45
Total Liabilities & Shareholders' Equity	3.13	4.35	1.69	1.09	0.8
Total Common Shares Outstanding